{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:27:30Z","timestamp":1794850050913,"version":"4.9.1"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873444, No. 82070213, and No.82370196"],"award-info":[{"award-number":["No. 81873444, No. 82070213, and No.82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873444, No. 82070213, and No.82370196"],"award-info":[{"award-number":["No. 81873444, No. 82070213, and No.82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873444, No. 82070213, and No.82370196"],"award-info":[{"award-number":["No. 81873444, No. 82070213, and No.82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873444, No. 82070213, and No.82370196"],"award-info":[{"award-number":["No. 81873444, No. 82070213, and No.82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81873444, No. 82070213, and No.82370196"],"award-info":[{"award-number":["No. 81873444, No. 82070213, and No.82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12015-025-11011-6","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T19:10:39Z","timestamp":1763493039000},"page":"434-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mesenchymal Stromal Cells: Bridging the Gaps in Hematologic Disease Therapy"],"prefix":"10.1007","volume":"22","author":[{"given":"Xumeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"11011_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/JBM.S346091","volume":"13","author":"H Ebrahim","year":"2022","unstructured":"Ebrahim, H., Fisha, T., Debash, H., & Bisetegn, H. (2022). Patterns of bone marrow confirmed malignant and non-malignant hematological disorders in patients with abnormal hematological parameters in Northeast Ethiopia. Journal of Blood Medicine, 13, 51\u201360.","journal-title":"Journal of Blood Medicine"},{"key":"11011_CR2","doi-asserted-by":"crossref","unstructured":"Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B., de O, Berti, E., et al. (2022). The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia, 36(7), 1720\u20131748.","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"7","key":"11011_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury, J. D., Solary, E., Abla, O., Akkari, Y., Alaggio, R., Apperley, J. F., et al. (2022). The 5th edition of the world health organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms. Leukemia, 36(7), 1703\u20131719.","journal-title":"Leukemia"},{"issue":"11","key":"11011_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11912-022-01299-9","volume":"24","author":"DC de Leeuw","year":"2022","unstructured":"de Leeuw, D. C., Ossenkoppele, G. J., & Janssen, J. J. W. M. (2022). Older patients with acute myeloid leukemia deserve individualized treatment. Current Oncology Reports, 24(11), 1387\u20131400.","journal-title":"Current Oncology Reports"},{"issue":"1","key":"11011_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali, R. S., Pratz, K. W., & Lai, C. (2023). Recent advances in targeted therapies in acute myeloid leukemia. Journal of Hematology & Oncology, 16(1), 29.","journal-title":"Journal of Hematology & Oncology"},{"key":"11011_CR6","first-page":"1","volume":"42","author":"GW Roloff","year":"2022","unstructured":"Roloff, G. W., Odenike, O., Bajel, A., Wei, A. H., Foley, N., & Uy, G. L. (2022). Contemporary approach to acute myeloid leukemia therapy in 2022. American Society of Clinical Oncology Educational Book American Society of Clinical Oncology Annual Meeting, 42, 1\u201316.","journal-title":"American Society of Clinical Oncology Educational Book American Society of Clinical Oncology Annual Meeting"},{"issue":"3","key":"11011_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/oncolo\/oyad306","volume":"29","author":"A Rafae","year":"2024","unstructured":"Rafae, A., van Rhee, F., & Al Hadidi, S. (2024). Perspectives on the treatment of multiple myeloma. The Oncologist, 29(3), 200\u2013212.","journal-title":"The Oncologist"},{"issue":"3","key":"11011_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41374-020-00515-z","volume":"101","author":"J Li","year":"2021","unstructured":"Li, J., Xia, Y., Fan, X., Wu, X., Yang, F., Hu, S., et al. (2021). Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation. Laboratory Investigation, 101(3), 318\u2013327.","journal-title":"Laboratory Investigation"},{"key":"11011_CR9","doi-asserted-by":"crossref","unstructured":"Shah, U. A., & Mailankody, S. (2020). Emerging immunotherapies in multiple myeloma. BMJ Clin res ed,\u00a0370, m3176. Sept 21;","DOI":"10.1136\/bmj.m3176"},{"issue":"9","key":"11011_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8(9), 726\u2013736.","journal-title":"Nature Reviews Immunology"},{"issue":"8","key":"11011_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136991","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen, X., Wang, C., Yin, J., Xu, J., Wei, J., & Zhang, Y. (2015). Efficacy of mesenchymal stem cell therapy for steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. PLoS One, 10(8), Article e0136991.","journal-title":"PLoS One"},{"issue":"3","key":"11011_CR12","first-page":"381","volume":"16","author":"AJ Friedenstein","year":"1966","unstructured":"Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 16(3), 381\u2013390.","journal-title":"Journal of Embryology and Experimental Morphology"},{"issue":"4","key":"11011_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315\u2013317.","journal-title":"Cytotherapy"},{"issue":"3","key":"11011_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s13577-021-00501-7","volume":"34","author":"D Ji","year":"2021","unstructured":"Ji, D., He, Y., Lu, W., Rong, Y., Li, F., Huang, X., et al. (2021). Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion. Human Cell, 34(3), 965\u2013976.","journal-title":"Human Cell"},{"issue":"12","key":"11011_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06325-7","volume":"14","author":"X Liao","year":"2023","unstructured":"Liao, X., Cai, D., Liu, J., Hu, H., You, R., Pan, Z., et al. (2023). Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy. Cell Death and Disease, 14(12), Article 796.","journal-title":"Cell Death and Disease"},{"issue":"3","key":"11011_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12015-020-09960-1","volume":"16","author":"B Zoehler","year":"2020","unstructured":"Zoehler, B., Fracaro, L., Senegaglia, A. C., & Bicalho, M. D. G. (2020). Infusion of mesenchymal stem cells to treat graft versus host disease: The role of HLA-G and the impact of its polymorphisms. Stem Cell Reviews and Reports, 16(3), 459\u2013471.","journal-title":"Stem Cell Reviews and Reports"},{"key":"11011_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107437","volume":"94","author":"X Wang","year":"2021","unstructured":"Wang, X., Yang, Y., Wang, N., Wu, X., Xu, J., Zhou, Y., et al. (2021). Mesenchymal stem cell carriers enhance antitumor efficacy induced by oncolytic reovirus in acute myeloid leukemia. International Immunopharmacology, 94, Article 107437.","journal-title":"International Immunopharmacology"},{"issue":"2","key":"11011_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bph.16028","volume":"181","author":"KE Miari","year":"2024","unstructured":"Miari, K. E., & Williams, M. T. S. (2024). Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance. British Journal of Pharmacology, 181(2), 216\u2013237.","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"11011_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10238-021-00701-3","volume":"21","author":"QZ Shi","year":"2021","unstructured":"Shi, Q. Z., Yu, H. M., Chen, H. M., Liu, M., & Cheng, X. (2021). Exosomes derived from mesenchymal stem cells regulate treg\/Th17 balance in aplastic anemia by transferring miR-23a-3p. Clinical and Experimental Medicine, 21(3), 429\u2013437.","journal-title":"Clinical and Experimental Medicine"},{"key":"11011_CR20","doi-asserted-by":"crossref","unstructured":"Kim, N., Min, G. J., Im, K. I., Nam, Y. S., Song, Y., Lee, J. S. (2024). Repeated infusions of bone-marrow-derived mesenchymal stem cells over 8 weeks for steroid-refractory chronic graft-versus-host disease: a prospective, phase I\/II clinical study. Int J Mol Sci,\u00a025(12):6731.\u00a0June 19","DOI":"10.3390\/ijms25126731"},{"issue":"8","key":"11011_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/MBC.0000000000000642","volume":"28","author":"Y Tao","year":"2017","unstructured":"Tao, Y., Song, D., Zhang, F., Ren, S., Zhang, H., & Sun, L. (2017). Transplantation of bone-marrow-derived mesenchymal stem cells into a murine model of immune thrombocytopenia. Blood Coagulation & Fibrinolysis, 28(8), 596\u2013601.","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"7","key":"11011_CR22","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1002\/jcb.28405","volume":"120","author":"P Zhang","year":"2019","unstructured":"Zhang, P., Zhang, G., Liu, X., Liu, H., Yang, P., & Ma, L. (2019). Mesenchymal stem cells improve platelet counts in mice with immune thrombocytopenia. Journal of Cellular Biochemistry, 120(7), 11274\u201311283.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"7","key":"11011_CR23","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.apsb.2023.05.007","volume":"13","author":"L Sun","year":"2023","unstructured":"Sun, L., Yang, N., Chen, B., Bei, Y., Kang, Z., Zhang, C., et al. (2023). A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharmaceutica Sinica B, 13(7), 3027\u20133042.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"11011_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631353","volume":"12","author":"M Mendt","year":"2021","unstructured":"Mendt, M., Daher, M., Basar, R., Shanley, M., Kumar, B., Wei Inng, F. L., et al. (2021). Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD. Frontiers in Immunology, 12, Article 631353.","journal-title":"Frontiers in Immunology"},{"key":"11011_CR25","doi-asserted-by":"crossref","unstructured":"Zhao, L., Chen, S., Yang, P., Cao, H., & Li, L. (2019). The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Stem Cell Res Ther,\u00a010(1), 182.","DOI":"10.1186\/s13287-019-1287-9"},{"key":"11011_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2019.03.004","volume":"55","author":"Y Nishi","year":"2019","unstructured":"Nishi, Y., Murakami, A., Murayama, Y., Tsukahara, N., Okamoto, S., Nakachi, S., et al. (2019). Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models. Transplant Immunology, 55, Article 101205.","journal-title":"Transplant Immunology"},{"issue":"2","key":"11011_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","volume":"18","author":"ON Ko\u00e7","year":"2000","unstructured":"Ko\u00e7, O. N., Gerson, S. L., Cooper, B. W., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I., et al. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol: Off J Am Soc Clin Oncol, 18(2), 307\u2013316.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"11011_CR28","doi-asserted-by":"crossref","unstructured":"Dias, I. X., Cordeiro, A., Guimar\u00e3es, J. A. M., & Silva, K. R. (2023). Potential and limitations of induced pluripotent stem cells-derived mesenchymal stem cells in musculoskeletal disorders treatment. Biomolecules, 13(9), 1342.","DOI":"10.3390\/biom13091342"},{"issue":"8","key":"11011_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081922","volume":"20","author":"A Abdal Dayem","year":"2019","unstructured":"Abdal Dayem, A., Lee, S. B., Kim, K., Lim, K. M., Jeon, T. I., Seok, J., et al. (2019). Production of mesenchymal stem cells through stem cell reprogramming. International Journal of Molecular Sciences, 20(8), Article 1922.","journal-title":"International Journal of Molecular Sciences"},{"key":"11011_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1005926","volume":"10","author":"K Thanaskody","year":"2022","unstructured":"Thanaskody, K., Jusop, A. S., Tye, G. J., Wan Kamarul Zaman, W. S., Dass, S. A., & Nordin, F. (2022). MSCs vs. iPSCs: Potential in therapeutic applications. Frontiers in Cell and Developmental Biology, 10, Article 1005926.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"11011_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40778-016-0060-6","volume":"2","author":"MD West","year":"2016","unstructured":"West, M. D., Nasonkin, I., Larocca, D., Chapman, K. B., Binette, F., & Sternberg, H. (2016). Adult versus pluripotent stem cell-derived mesenchymal stem cells: The need for more precise nomenclature. Current Stem Cell Reports, 2(3), 299\u2013303.","journal-title":"Current Stem Cell Reports"},{"key":"11011_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.lfs.2018.10.061","volume":"214","author":"Y Ma","year":"2018","unstructured":"Ma, Y., Wang, Z., Zhang, A., Xu, F., Zhao, N., Xue, J., et al. (2018). Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17\/Tr1 balance via expression of PD-L2. Life Sciences, 214, 98\u2013105.","journal-title":"Life Sciences"},{"issue":"1","key":"11011_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81916-y","volume":"11","author":"Y Tago","year":"2021","unstructured":"Tago, Y., Kobayashi, C., Ogura, M., Wada, J., Yamaguchi, S., Yamaguchi, T., et al. (2021). Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation. Scientific Reports, 11(1), Article 2406.","journal-title":"Scientific Reports"},{"key":"11011_CR34","doi-asserted-by":"crossref","unstructured":"Yamahara, K., Hamada, A., Soma, T., Okamoto, R., Okada, M., Yoshihara, S. (2019). Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I\/II japanese trial. BMJ open\u00a09(7), e026403.","DOI":"10.1136\/bmjopen-2018-026403"},{"key":"11011_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00068","volume":"8","author":"F Huang","year":"2017","unstructured":"Huang, F., Chen, M., Chen, W., Gu, J., Yuan, J., Xue, Y., et al. (2017). Human gingiva-derived mesenchymal stem cells inhibit xeno-graft-versus-host disease via CD39-CD73-adenosine and IDO signals. Frontiers in Immunology, 8, Article 68.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"11011_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1273-7","volume":"10","author":"X Ni","year":"2019","unstructured":"Ni, X., Xia, Y., Zhou, S., Peng, H., Wu, X., Lu, H., et al. (2019). Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways. Cell Death and Disease, 10(1), Article 13.","journal-title":"Cell Death and Disease"},{"issue":"5","key":"11011_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., et al. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 7(5), 393\u2013395.","journal-title":"Cytotherapy"},{"key":"11011_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.859668","volume":"13","author":"K Atmar","year":"2022","unstructured":"Atmar, K., Tulling, A. J., Lankester, A. C., Bartels, M., Smiers, F. J., van der Burg, M., et al. (2022). Functional and immune modulatory characteristics of bone marrow mesenchymal stromal cells in patients with aplastic anemia: A systematic review. Frontiers in Immunology, 13, Article 859668.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"11011_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01793-5","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Xu, Y., Chi, Y., Sun, T., Gao, Y., Dou, X., et al. (2024). Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: A prospective, single arm, phase I trial. Signal Transduction and Targeted Therapy, 9(1), Article 102.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"11011_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-023-03417-1","volume":"14","author":"C He","year":"2023","unstructured":"He, C., Yang, C., Zeng, Q., Liu, Z., Wang, F., Chen, Q., et al. (2023). Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy. Stem Cell Research & Therapy, 14(1), 224.","journal-title":"Stem Cell Research & Therapy"},{"key":"11011_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720965411","volume":"11","author":"Z Liu","year":"2020","unstructured":"Liu, Z., Wu, X., Wang, S., Xia, L., Xiao, H., Li, Y., et al. (2020). Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia. Therapeutic Advances in Hematology, 11, Article 2040620720965411.","journal-title":"Therapeutic Advances in Hematology"},{"key":"11011_CR42","doi-asserted-by":"crossref","unstructured":"Sheng, X. F., Li, H., Hong, L. L., & Zhuang, H. (2022). Combination of haploidentical hematopoietic stem cell transplantation with umbilical cord-derived mesenchymal stem cells in patients with severe aplastic anemia: a retrospective controlled study. Turk J Haematol: Off J Turk Soc Haematol, 39(2), 117\u201329.","DOI":"10.4274\/tjh.galenos.2022.2022.0084"},{"issue":"1","key":"11011_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-018-0311-3","volume":"23","author":"L Xu","year":"2018","unstructured":"Xu, L., Liu, Z., Wu, Y., Yang, X., Cao, Y., Li, X., et al. (2018). Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia. European Journal of Medical Research, 23(1), Article 12.","journal-title":"European Journal of Medical Research"},{"issue":"1","key":"11011_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07305-0","volume":"24","author":"D Yang","year":"2023","unstructured":"Yang, D., Hou, X., Qian, K., Li, Y., Hu, L., Li, L., et al. (2023). Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: A study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial. Trials, 24(1), Article 306.","journal-title":"Trials"},{"issue":"5","key":"11011_CR45","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/bjh.16953","volume":"191","author":"H Li","year":"2020","unstructured":"Li, H., Guan, Y., Sun, B., Dou, X., Liu, X., Xue, F., et al. (2020). Role of bone marrow-derived mesenchymal stem cell defects in CD8\u2009+\u2009CD28- suppressor T-lymphocyte induction in patients with immune thrombocytopenia and associated mechanisms. British Journal of Haematology, 191(5), 852\u2013862.","journal-title":"British Journal of Haematology"},{"issue":"11","key":"11011_CR46","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jcyt.2021.07.009","volume":"23","author":"R Wang","year":"2021","unstructured":"Wang, R., Wang, X., Yang, S., Xiao, Y., Jia, Y., Zhong, J., et al. (2021). Umbilical cord-derived mesenchymal stem cells promote myeloid-derived suppressor cell enrichment by secreting CXCL1 to prevent graft-versus-host disease after hematopoietic stem cell transplantation. Cytotherapy, 23(11), 996\u20131006.","journal-title":"Cytotherapy"},{"issue":"1","key":"11011_CR47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13287-024-03947-2","volume":"15","author":"M Mendiratta","year":"2024","unstructured":"Mendiratta, M., Mendiratta, M., Ganguly, S., Rai, S., Gupta, R., Kumar, L., et al. (2024). Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model. Stem Cell Research & Therapy, 15(1), 381.","journal-title":"Stem Cell Research & Therapy"},{"key":"11011_CR48","doi-asserted-by":"crossref","unstructured":"Bu, Z., Lou, J., Xu, W., Zhang, L., & Tang, Y. (2024). Human umbilical cord mesenchymal stem cell-based gene therapy for hemophilia B using scAAV-DJ\/8-LP1-hFIXco transduction. Stem Cell Res Ther, 15(1), 210.","DOI":"10.1186\/s13287-024-03824-y"},{"issue":"11","key":"11011_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111391","volume":"15","author":"F Chen","year":"2022","unstructured":"Chen, F., Zhong, X., Dai, Q., Li, K., Zhang, W., Wang, J., et al. (2022). Human umbilical cord MSC delivered-soluble TRAIL inhibits the proliferation and promotes apoptosis of B-ALL cell in vitro and in vivo. Pharmaceuticals, 15(11), Article 1391.","journal-title":"Pharmaceuticals"},{"issue":"8","key":"11011_CR50","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1007\/s12015-024-10780-w","volume":"20","author":"X Hao","year":"2024","unstructured":"Hao, X., Zhu, H., Qin, C., Li, L., Lin, Z., Jiang, H., et al. (2024). Study on preclinical safety and toxic mechanism of human umbilical cord mesenchymal stem cells in F344RG rats. Stem Cell Reviews and Reports, 20(8), 2236\u20132252.","journal-title":"Stem Cell Reviews and Reports"},{"key":"11011_CR51","doi-asserted-by":"crossref","unstructured":"Marino, L., Castaldi, M. A., Rosamilio, R., Ragni, E., Vitolo, R., Fulgione, C. (2019). Mesenchymal stem cells from the wharton\u2019s jelly of the human umbilical cord: biological properties and therapeutic potential. Int J Stem Cells, 3112(2), 218\u201326.","DOI":"10.15283\/ijsc18034"},{"issue":"1","key":"11011_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.retram.2019.09.001","volume":"68","author":"LL Liau","year":"2020","unstructured":"Liau, L. L., Ruszymah, B. H. I., Ng, M. H., & Law, J. X. (2020). Characteristics and clinical applications of wharton\u2019s jelly-derived mesenchymal stromal cells. Current Research in Translational Medicine, 68(1), 5\u201316.","journal-title":"Current Research in Translational Medicine"},{"issue":"6","key":"11011_CR53","doi-asserted-by":"publisher","first-page":"11692","DOI":"10.3390\/ijms140611692","volume":"14","author":"DW Kim","year":"2013","unstructured":"Kim, D. W., Staples, M., Shinozuka, K., Pantcheva, P., Kang, S. D., & Borlongan, C. V. (2013). Wharton\u2019s jelly-derived mesenchymal stem cells: Phenotypic characterization and optimizing their therapeutic potential for clinical applications. International Journal of Molecular Sciences, 14(6), 11692\u201311712.","journal-title":"International Journal of Molecular Sciences"},{"key":"11011_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1211217","volume":"11","author":"H Drobiova","year":"2023","unstructured":"Drobiova, H., Sindhu, S., Ahmad, R., Haddad, D., Al-Mulla, F., & Al Madhoun, A. (2023). Wharton\u2019s jelly mesenchymal stem cells: A concise review of their secretome and prospective clinical applications. Frontiers in Cell and Developmental Biology, 11, Article 1211217.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"2","key":"11011_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3727\/096368915X688155","volume":"25","author":"J Zhang","year":"2016","unstructured":"Zhang, J., Zhou, S., Zhou, Y., Feng, F., Wang, Q., Zhu, X., et al. (2016). Adipose-derived mesenchymal stem cells (ADSCs) with the potential to ameliorate platelet recovery, enhance megakaryopoiesis, and inhibit apoptosis of bone marrow cells in a mouse model of radiation-induced thrombocytopenia. Cell Transplantation, 25(2), 261\u2013273.","journal-title":"Cell Transplantation"},{"issue":"1","key":"11011_CR56","first-page":"609","volume":"19","author":"KA Cho","year":"2019","unstructured":"Cho, K. A., Kim, Y. H., Park, M., Kim, H. J., Woo, S. Y., Park, J. W., et al. (2019). Conditioned medium from human palatine tonsil mesenchymal stem cells attenuates acute graft\u2013vs.\u2013host disease in mice. Molecular Medicine Reports, 19(1), 609\u2013616.","journal-title":"Molecular Medicine Reports"},{"key":"11011_CR57","doi-asserted-by":"publisher","first-page":"792142","DOI":"10.3389\/fonc.2021.792142","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang, Q., Xu, N., Wang, Y., Zhang, X., Liu, L., Zhou, H., et al. (2021). Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: A multicenter retrospective study. Frontiers in Oncology, 11, 792142.","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"11011_CR58","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s13577-021-00547-7","volume":"34","author":"Y He","year":"2021","unstructured":"He, Y., Ji, D., Lu, W., Li, F., Huang, X., Huang, R., et al. (2021). Bone marrow mesenchymal stem cell-derived exosomes induce the Th17\/Treg imbalance in immune thrombocytopenia through miR-146a-5p\/IRAK1 axis. Human Cell, 34(5), 1360\u20131374.","journal-title":"Human Cell"},{"issue":"2","key":"11011_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/sctm.20-0345","volume":"10","author":"L Ding","year":"2021","unstructured":"Ding, L., Han, D. M., Zheng, X. L., Yan, H. M., Xue, M., Liu, J., et al. (2021). A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients. Stem Cells Translational Medicine, 10(2), 291\u2013302.","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"11011_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamaoncol.2023.5757","volume":"10","author":"R Huang","year":"2024","unstructured":"Huang, R., Chen, T., Wang, S., Wang, J., Su, Y., Liu, J., et al. (2024). Mesenchymal stem cells for prophylaxis of chronic graft-vs-host disease after haploidentical hematopoietic stem cell transplant: An open-label randomized clinical trial. JAMA Oncology, 10(2), 220\u2013226.","journal-title":"JAMA Oncology"},{"issue":"1","key":"11011_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000506759","volume":"145","author":"C Ma","year":"2022","unstructured":"Ma, C., Feng, Y., Yang, L., Wang, S., Sun, X., Tai, S., et al. (2022). In vitro immunomodulatory effects of human umbilical cord-derived mesenchymal stem cells on peripheral blood cells from warm autoimmune hemolytic anemia patients. Acta Haematologica, 145(1), 63\u201371.","journal-title":"Acta Haematologica"},{"issue":"8","key":"11011_CR62","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1002\/jcp.30291","volume":"236","author":"MA Gholampour","year":"2021","unstructured":"Gholampour, M. A., Abroun, S., Nieuwland, R., Mowla, S. J., & Soudi, S. (2021). Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model. Journal of Cellular Physiology, 236(8), 6055\u20136067.","journal-title":"Journal of Cellular Physiology"},{"key":"11011_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609277","volume":"11","author":"AJ Burnham","year":"2020","unstructured":"Burnham, A. J., Foppiani, E. M., & Horwitz, E. M. (2020). Key metabolic pathways in MSC-mediated immunomodulation: Implications for the prophylaxis and treatment of graft versus host disease. Frontiers in Immunology, 11, Article 609277.","journal-title":"Frontiers in Immunology"},{"key":"11011_CR64","doi-asserted-by":"crossref","unstructured":"Lim, J. Y., Ryu, D. B., Lee, S. E., Park, G., & Min, C. K. (2017). Mesenchymal stem cells (MSCs) attenuate cutaneous sclerodermatous graft-versus-host disease (scl-GVHD) through Inhibition of immune cell infiltration in a mouse model. The Journal of Investigative Dermatology, 137(9), 1895\u20131904.","DOI":"10.1016\/j.jid.2017.02.986"},{"issue":"1","key":"11011_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03594-1","volume":"73","author":"R Towers","year":"2024","unstructured":"Towers, R., Trombello, L., Fusenig, M., Tunger, A., Baumann, A. L., Savoldelli, R., et al. (2024). Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8\u2009+\u2009clonal effector and CAR T-cell function while promoting a senescence-associated phenotype. Cancer Immunology, Immunotherapy, 73(1), Article 8.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"11011_CR66","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4024887","volume":"2023","author":"Y Yuan","year":"2023","unstructured":"Yuan, Y., Tan, S., Wang, H., Zhu, J., Li, J., Zhang, P., et al. (2023). Mesenchymal stem cell-derived exosomal miRNA-222-3p increases Th1\/TH2 ratio and promotes apoptosis of acute myeloid leukemia cells. Analytical Cellular Pathology (Amsterdam), 2023, Article 4024887.","journal-title":"Analytical Cellular Pathology (Amsterdam)"},{"key":"11011_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1284936","volume":"14","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y., Zhao, J., Wang, M., Huang, F., Li, J., Liu, R., et al. (2023). Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models. Frontiers in Immunology, 14, Article 1284936.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"11011_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13287-021-02159-2","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu, W., Zhou, N., Liu, Y., Zhang, W., Li, X., Wang, Y., et al. (2021). Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells. Stem Cell Research & Therapy, 12(1), 153.","journal-title":"Stem Cell Research & Therapy"},{"key":"11011_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01193-z","volume":"20","author":"X Zhou","year":"2020","unstructured":"Zhou, X., Jin, N., Wang, F., & Chen, B. (2020). Mesenchymal stem cells: A promising way in therapies of graft-versus-host disease. Cancer Cell International, 20, Article 114.","journal-title":"Cancer Cell International"},{"issue":"12","key":"11011_CR70","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.humimm.2019.10.006","volume":"80","author":"M Mahmoudi","year":"2019","unstructured":"Mahmoudi, M., Taghavi-Farahabadi, M., Namaki, S., Baghaei, K., Rayzan, E., Rezaei, N., et al. (2019). Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro. Human Immunology, 80(12), 990\u2013998.","journal-title":"Human Immunology"},{"key":"11011_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106463","volume":"83","author":"M Taghavi-Farahabadi","year":"2020","unstructured":"Taghavi-Farahabadi, M., Mahmoudi, M., Hashemi, S. M., & Rezaei, N. (2020). Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. International Immunopharmacology, 83, Article 106463.","journal-title":"International Immunopharmacology"},{"issue":"12","key":"11011_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4252\/wjsc.v9.i12.219","volume":"9","author":"L Broglie","year":"2017","unstructured":"Broglie, L., Margolis, D., & Medin, J. A. (2017). Yin and yang of mesenchymal stem cells and aplastic anemia. World Journal of Stem Cells, 9(12), 219\u2013226.","journal-title":"World Journal of Stem Cells"},{"key":"11011_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1325291","volume":"11","author":"AK Singh","year":"2023","unstructured":"Singh, A. K., Prasad, P., & Cancelas, J. A. (2023). Mesenchymal stromal cells, metabolism, and mitochondrial transfer in bone marrow normal and malignant hematopoiesis. Frontiers in Cell and Developmental Biology, 11, Article 1325291.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"11011_CR74","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","volume":"32","author":"D Forte","year":"2020","unstructured":"Forte, D., Garc\u00eda-Fern\u00e1ndez, M., S\u00e1nchez-Aguilera, A., Stavropoulou, V., Fielding, C., Mart\u00edn-P\u00e9rez, D., et al. (2020). Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metabolism, 32(5), 829-843e9.","journal-title":"Cell Metabolism"},{"key":"11011_CR75","doi-asserted-by":"crossref","unstructured":"Moschoi, R., Imbert, V., Nebout, M., Chiche, J., Mary, D., Prebet, T. (2016). Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood, 128(2), 253\u2013264.","DOI":"10.1182\/blood-2015-07-655860"},{"issue":"10","key":"11011_CR76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220953","volume":"220","author":"L Sandhow","year":"2023","unstructured":"Sandhow, L., Cai, H., Leonard, E., Xiao, P., Tomaipitinca, L., M\u00e5nsson, A., et al. (2023). Skin mesenchymal niches maintain and protect AML-initiating stem cells. Journal of Experimental Medicine, 220(10), Article e20220953.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"11011_CR77","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13287-023-03543-w","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang, H., Cheong, S., He, Y., & Lu, F. (2023). Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease. Stem Cell Research & Therapy, 14(1), 372.","journal-title":"Stem Cell Research & Therapy"},{"issue":"3","key":"11011_CR78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. (2020). Transforming growth factor-\u03b2 in tissue fibrosis. Journal of Experimental Medicine, 217(3), Article e20190103.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"11011_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han, Y., Yang, J., Fang, J., Zhou, Y., Candi, E., Wang, J., et al. (2022). The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduction and Targeted Therapy, 7(1), Article 92.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"11011_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021277","volume":"24","author":"Y Su","year":"2023","unstructured":"Su, Y., Xu, C., Cheng, W., Zhao, Y., Sui, L., & Zhao, Y. (2023). Pretreated mesenchymal stem cells and their secretome: Enhanced immunotherapeutic strategies. International Journal of Molecular Sciences, 24(2), Article 1277.","journal-title":"International Journal of Molecular Sciences"},{"key":"11011_CR81","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jconrel.2023.01.059","volume":"354","author":"K Malekpour","year":"2023","unstructured":"Malekpour, K., Hazrati, A., Soudi, S., & Hashemi, S. M. (2023). Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer\/delivery. Journal of Controlled Release, 354, 755\u2013769.","journal-title":"Journal of Controlled Release"},{"issue":"24","key":"11011_CR82","first-page":"181","volume":"S2090-1232","author":"CM Trigo","year":"2024","unstructured":"Trigo, C. M., Rodrigues, J. S., Cam\u00f5es, S. P., Sol\u00e1, S., & Miranda, J. P. (2024). Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? Journal of Advanced Research, S2090-1232(24), 181\u2013184.","journal-title":"Journal of Advanced Research"},{"key":"11011_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkae062","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Wu, D., Zhou, C., Bai, M., Wan, Y., Zheng, Q., et al. (2024). Engineered extracellular vesicles for tissue repair and regeneration. Burns & Trauma, 12, Article tkae062.","journal-title":"Burns & Trauma"},{"issue":"5","key":"11011_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052527","volume":"25","author":"CH Wu","year":"2024","unstructured":"Wu, C. H., Weng, T. F., Li, J. P., & Wu, K. H. (2024). Biology and therapeutic properties of mesenchymal stem cells in leukemia. International Journal of Molecular Sciences, 25(5), Article 2527.","journal-title":"International Journal of Molecular Sciences"},{"key":"11011_CR85","doi-asserted-by":"publisher","DOI":"10.1177\/0963689719885077","volume":"29","author":"VH Sarmadi","year":"2020","unstructured":"Sarmadi, V. H., Ahmadloo, S., Boroojerdi, M. H., John, C. M., Al-Graitte, S. J. R., Lawal, H., et al. (2020). Human mesenchymal stem cells-mediated transcriptomic regulation of leukemic cells in delivering anti-tumorigenic effects. Cell Transplantation, 29, Article 963689719885077.","journal-title":"Cell Transplantation"},{"issue":"7","key":"11011_CR86","first-page":"557","volume":"138","author":"G Borella","year":"2021","unstructured":"Borella, G., Da Ros, A., Borile, G., Porc\u00f9, E., Tregnago, C., Benetton, M., et al. (2021). Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia. Blood, 138(7), 557\u2013570.","journal-title":"Blood"},{"issue":"4","key":"11011_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16810","volume":"190","author":"A Chowdhury","year":"2020","unstructured":"Chowdhury, A., Loaiza, S., Yebra-Fernandez, E., Nadal-Melsio, E., Apperley, J. F., & Khorashad, J. S. (2020). An ex vivo investigation of interactions between primary acute myeloid leukaemia and mesenchymal stromal cells yields novel therapeutic targets. British Journal of Haematology, 190(4), Article e236\u2013e239.","journal-title":"British Journal of Haematology"},{"issue":"2","key":"11011_CR88","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/hon.2793","volume":"39","author":"T Lyu","year":"2021","unstructured":"Lyu, T., Zhang, B., Li, M., Jiao, X., & Song, Y. (2021). Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies. Hematological Oncology, 39(2), 162\u2013169.","journal-title":"Hematological Oncology"},{"issue":"1","key":"11011_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-021-01206-7","volume":"20","author":"D Jiang","year":"2022","unstructured":"Jiang, D., Wu, X., Sun, X., Tan, W., Dai, X., Xie, Y., et al. (2022). Bone mesenchymal stem cell-derived Exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11. J Nanobiotechnology, 20(1), 29.","journal-title":"J Nanobiotechnology"},{"key":"11011_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2020.101513","volume":"51","author":"F Zhang","year":"2020","unstructured":"Zhang, F., Lu, Y., Wang, M., Zhu, J., Li, J., Zhang, P., et al. (2020). Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2\/INPP4B. Molecular and Cellular Probes, 51, Article 101513.","journal-title":"Molecular and Cellular Probes"},{"issue":"1","key":"11011_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00393-1","volume":"27","author":"H Cheng","year":"2021","unstructured":"Cheng, H., Ding, J., Tang, G., Huang, A., Gao, L., Yang, J., et al. (2021). Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p\/TRIM14 pathway. Molecular Medicine, 27(1), Article 128.","journal-title":"Molecular Medicine"},{"issue":"23","key":"11011_CR92","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1097\/CM9.0000000000001138","volume":"133","author":"YC Xu","year":"2020","unstructured":"Xu, Y. C., Lin, Y. S., Zhang, L., Lu, Y., Sun, Y. L., Fang, Z. G., et al. (2020). MicroRNAs of bone marrow mesenchymal stem cell-derived exosomes regulate acute myeloid leukemia cell proliferation and apoptosis. Chinese Medical Journal, 133(23), 2829\u20132839.","journal-title":"Chinese Medical Journal"},{"issue":"1","key":"11011_CR93","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2428482","volume":"29","author":"F Wang","year":"2024","unstructured":"Wang, F. (2024). Mechanism of bone-marrow mesenchymal stem cell-derived exosomes mediating microRNA-139-5p to regulate \u03b2-catenin in the modulation of proliferation and apoptosis of acute myeloid leukemia cells. Hematology, 29(1), Article 2428482.","journal-title":"Hematology"},{"issue":"1","key":"11011_CR94","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01364-6","volume":"24","author":"S Jalilivand","year":"2024","unstructured":"Jalilivand, S., Izadirad, M., Vazifeh Shiran, N., Gharehbaghian, A., & Naserian, S. (2024). The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia\u2019s biological functions: A focus on the potential role of LncRNAs. Clinical and Experimental Medicine, 24(1), Article 108.","journal-title":"Clinical and Experimental Medicine"},{"issue":"3","key":"11011_CR95","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41375-018-0373-9","volume":"33","author":"MW Lee","year":"2019","unstructured":"Lee, M. W., Ryu, S., Kim, D. S., Lee, J. W., Sung, K. W., Koo, H. H., et al. (2019). Mesenchymal stem cells in suppression or progression of hematologic malignancy: Current status and challenges. Leukemia, 33(3), 597\u2013611.","journal-title":"Leukemia"},{"issue":"12","key":"11011_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121701","volume":"13","author":"S Giallongo","year":"2023","unstructured":"Giallongo, S., Duminuco, A., Dulcamare, I., Zuppelli, T., La Spina, E., Scandura, G., et al. (2023). Engagement of mesenchymal stromal cells in the remodeling of the bone marrow microenvironment in hematological cancers. Biomolecules, 13(12), Article 1701.","journal-title":"Biomolecules"},{"issue":"6","key":"11011_CR97","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.celrep.2019.01.034","volume":"26","author":"Z Ma","year":"2019","unstructured":"Ma, Z., Zhao, X., Deng, M., Huang, Z., Wang, J., Wu, Y., et al. (2019). Bone marrow mesenchymal stromal cell-derived periostin promotes B-ALL progression by modulating CCL2 in leukemia cells. Cell Reports, 26(6), 1533-1543e4.","journal-title":"Cell Reports"},{"issue":"5","key":"11011_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0545-6","volume":"9","author":"J Guo","year":"2018","unstructured":"Guo, J., Zhao, Y., Fei, C., Zhao, S., Zheng, Q., Su, J., et al. (2018). Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death and Disease, 9(5), Article 512.","journal-title":"Cell Death and Disease"},{"issue":"1","key":"11011_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1081-7","volume":"38","author":"W Zhong","year":"2019","unstructured":"Zhong, W., Zhu, Z., Xu, X., Zhang, H., Xiong, H., Li, Q., et al. (2019). Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels. Journal of Experimental & Clinical Cancer Research, 38(1), Article 73.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"32","key":"11011_CR100","doi-asserted-by":"publisher","first-page":"12167","DOI":"10.1074\/jbc.RA119.008037","volume":"294","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Tu, H., Yang, Y., Jiang, X., Hu, X., Luo, Q., et al. (2019). Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7\/JAK1\/STAT5 pathway. Journal of Biological Chemistry, 294(32), 12167\u201312179.","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"11011_CR101","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/leu.2016.187","volume":"31","author":"G McNee","year":"2017","unstructured":"McNee, G., Eales, K. L., Wei, W., Williams, D. S., Barkhuizen, A., Bartlett, D. B., et al. (2017). Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma. Leukemia, 31(2), 373\u2013381.","journal-title":"Leukemia"},{"key":"11011_CR102","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83533","volume":"12","author":"X Feng","year":"2023","unstructured":"Feng, X., Sun, R., Lee, M., Chen, X., Guo, S., Geng, H., et al. (2023). Cell circuits between leukemic cells and mesenchymal stem cells block lymphopoiesis by activating lymphotoxin beta receptor signaling. eLife, 12, Article e83533.","journal-title":"eLife"},{"issue":"6","key":"11011_CR103","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s12015-021-10235-6","volume":"17","author":"LS Sherman","year":"2021","unstructured":"Sherman, L. S., Patel, S. A., Castillo, M. D., Unkovic, R., Taborga, M., Gergues, M., et al. (2021). NF\u0138B targeting in bone marrow mesenchymal stem cell-mediated support of age-linked hematological malignancies. Stem Cell Reviews and Reports, 17(6), 2178\u20132192.","journal-title":"Stem Cell Reviews and Reports"},{"key":"11011_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1393482","volume":"15","author":"L Zheng","year":"2024","unstructured":"Zheng, L., Pan, C., Ma, D., Shang, Q., Hu, T., Zhang, T., et al. (2024). Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1\/CXCR4 axis. Frontiers in Pharmacology, 15, Article 1393482.","journal-title":"Frontiers in Pharmacology"},{"issue":"10","key":"11011_CR105","doi-asserted-by":"publisher","first-page":"18707","DOI":"10.1002\/jcp.28511","volume":"234","author":"M Zahedpanah","year":"2019","unstructured":"Zahedpanah, M., Takanlu, J. S., Nikbakht, M., Rad, F., Farhid, F., Mousavi, S. A., et al. (2019). Microvesicles of osteoblasts modulate bone marrow mesenchymal stem cell-induced apoptosis to curcumin in myeloid leukemia cells. Journal of Cellular Physiology, 234(10), 18707\u201318719.","journal-title":"Journal of Cellular Physiology"},{"key":"11011_CR106","unstructured":"L Z, H. L. J. L. J. C. X. C. Z L. (2019). AML\u2013derived mesenchymal stem cells upregulate CTGF expression through the BMP pathway and induce K562\u2013ADM fusiform transformation and chemoresistance. Oncology Reports,\u00a02019 42(3). [Internet] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31322275\/"},{"issue":"4","key":"11011_CR107","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1096\/fj.201801931R","volume":"33","author":"J Cheng","year":"2019","unstructured":"Cheng, J., Li, Y., Liu, S., Jiang, Y., Ma, J., Wan, L., et al. (2019). CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K\/AKT pathway. The FASEB Journal, 33(4), 4755\u20134764.","journal-title":"The FASEB Journal"},{"issue":"4","key":"11011_CR108","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/bjh.16253","volume":"189","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., Li, Y., Cheng, J., Ma, J., Li, Q., & Pang, T. (2020). Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells. British Journal of Haematology, 189(4), 694\u2013706.","journal-title":"British Journal of Haematology"},{"issue":"2","key":"11011_CR109","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbrc.2020.02.091","volume":"525","author":"Y Li","year":"2020","unstructured":"Li, Y., Jiang, Y., Cheng, J., Ma, J., Li, Q., & Pang, T. (2020). ATG5 regulates mesenchymal stem cells differentiation and mediates chemosensitivity in acute myeloid leukemia. Biochemical And Biophysical Research Communications, 525(2), 398\u2013405.","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"8","key":"11011_CR110","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/cas.15855","volume":"114","author":"J Lu","year":"2023","unstructured":"Lu, J., Dong, Q., Zhang, S., Feng, Y., Yang, J., & Zhao, L. (2023). Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6\/JAK2\/STAT3 signaling. Cancer Science, 114(8), 3287\u20133300.","journal-title":"Cancer Science"},{"key":"11011_CR111","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bbrc.2020.10.093","volume":"534","author":"M Rethnam","year":"2021","unstructured":"Rethnam, M., Tan, D. Q., & Suda, T. (2021). Myeloma cells self-promote migration by regulating tables 1-driven TIMP-1 expression in mesenchymal stem cells. Biochemical and Biophysical Research Communications, 534, 843\u2013848.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"11011_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1397005","volume":"15","author":"K Li","year":"2024","unstructured":"Li, K., Nie, H., Jin, R., & Wu, X. (2024). Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy. Frontiers in Immunology, 15, Article 1397005.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"11011_CR113","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1002\/jcp.27142","volume":"234","author":"N Jafarzadeh","year":"2019","unstructured":"Jafarzadeh, N., Safari, Z., Pornour, M., Amirizadeh, N., Forouzandeh Moghadam, M., & Sadeghizadeh, M. (2019). Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes. Journal of Cellular Physiology, 234(4), 3697\u20133710.","journal-title":"Journal of Cellular Physiology"},{"key":"11011_CR114","doi-asserted-by":"crossref","unstructured":"Alameda, D., Saez, B., Lara-Astiaso, D., Sarvide, S., Lasa, M., Alignani, D. (2020). Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment. Haematologica, 105(9), e470-473.","DOI":"10.3324\/haematol.2019.235135"},{"issue":"1","key":"11011_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00985-2","volume":"20","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Guo, Y., Huang, L., Jia, Y., Liu, H., Peng, F., et al. (2022). Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes. Cell Communication and Signaling, 20(1), Article 169.","journal-title":"Cell Communication and Signaling"},{"issue":"7","key":"11011_CR116","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15384101.2018.1442624","volume":"17","author":"D Chen","year":"2018","unstructured":"Chen, D., Tang, P., Liu, L., Wang, F., Xing, H., Sun, L., et al. (2018). Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1\/PD-L1 pathway. Cell Cycle, 17(7), 858\u2013867.","journal-title":"Cell Cycle"},{"issue":"9","key":"11011_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094748","volume":"25","author":"FA de Freitas","year":"2024","unstructured":"de Freitas, F. A., Levy, D., Reichert, C. O., Sampaio-Silva, J., Giglio, P. N., de P\u00e1dua Covas Lage, L. A., et al. (2024). Influence of human bone marrow mesenchymal stem cells secretome from acute myeloid leukemia patients on the proliferation and death of K562 and K562-lucena leukemia cell lineages. International Journal of Molecular Sciences, 25(9), Article 4748.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"11011_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02793-9","volume":"16","author":"X Gao","year":"2021","unstructured":"Gao, X., Zhou, J., Wang, J., Dong, X., Chang, Y., & Jin, Y. (2021). Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells. Journal Of Orthopaedic Surgery And Research, 16(1), Article 637.","journal-title":"Journal Of Orthopaedic Surgery And Research"},{"issue":"5","key":"11011_CR119","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/bjh.17425","volume":"193","author":"R Xu","year":"2021","unstructured":"Xu, R., Huang, X., Li, C., Deng, C., Li, M., Wu, P., et al. (2021). Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: Overactivated WNT\/\u03b2-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes. British Journal of Haematology, 193(5), 928\u2013940.","journal-title":"British Journal of Haematology"},{"key":"11011_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110610","volume":"130","author":"C Pan","year":"2020","unstructured":"Pan, C., Liu, P., Ma, D., Zhang, S., Ni, M., Fang, Q., et al. (2020). Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia. Biomedicine & Pharmacotherapy, 130, Article 110610.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11011_CR121","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9012152","volume":"2017","author":"Q Cheng","year":"2017","unstructured":"Cheng, Q., Li, X., Liu, J., Ye, Q., Chen, Y., & Tan, S. (2017). Multiple myeloma-derived exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a. Stem Cells International, 2017, Article 9012152.","journal-title":"Stem Cells International"},{"issue":"16","key":"11011_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105811","volume":"9","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Zhao, Q., Cang, H., Wang, Z., Hu, X., & Pan, R. (2022). Acute myeloid leukemia cells educate mesenchymal stromal cells toward an adipogenic differentiation propensity with leukemia promotion capabilities. Advanced Science, 9(16), Article 2105811.","journal-title":"Advanced Science"},{"issue":"2","key":"11011_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020449","volume":"12","author":"S Raimondo","year":"2020","unstructured":"Raimondo, S., Urz\u00ec, O., Conigliaro, A., Bosco, G. L., Parisi, S., Carlisi, M., et al. (2020). Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma. Cancers, 12(2), Article 449.","journal-title":"Cancers"},{"issue":"3","key":"11011_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12417","volume":"13","author":"VK Chetty","year":"2024","unstructured":"Chetty, V. K., Ghanam, J., Lich\u00e1, K., Brenzel, A., Reinhardt, D., & Thakur, B. K. (2024). Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts-implications for acute myeloid leukaemia. Journal of Extracellular Vesicles, 13(3), Article e12417.","journal-title":"Journal of Extracellular Vesicles"},{"key":"11011_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.708513","volume":"9","author":"C Pan","year":"2021","unstructured":"Pan, C., Fang, Q., Liu, P., Ma, D., Cao, S., Zhang, L., et al. (2021). Mesenchymal stem cells with cancer-associated fibroblast-like phenotype stimulate SDF-1\/CXCR4 axis to enhance the growth and invasion of B-cell acute lymphoblastic leukemia cells through cell-to-cell communication. Frontiers in Cell and Developmental Biology, 9, Article 708513.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"11","key":"11011_CR126","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.stem.2022.10.001","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Fang, J., Liu, B., Shao, C., & Shi, Y. (2022). Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell, 29(11), 1515\u20131530.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"11011_CR127","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.214031","volume":"105","author":"J \u00c5hsberg","year":"2020","unstructured":"\u00c5hsberg, J., Xiao, P., Okuyama, K., Somasundaram, R., Strid, T., Qian, H., et al. (2020). Progression of progenitor B-cell leukemia is associated with alterations of the bone marrow micro-environment. Haematologica, 105(3), Article e102\u2013e106.","journal-title":"Haematologica"},{"key":"11011_CR128","doi-asserted-by":"crossref","unstructured":"Xiao, P., Sandhow, L., Heshmati, Y., Kondo, M., Bouderlique, T., Dolinska, M. (2018) Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice. Blood Adv, 2(12), 1480\u20131494.","DOI":"10.1182\/bloodadvances.2017013870"},{"issue":"11","key":"11011_CR129","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.tem.2023.08.001","volume":"34","author":"ST Orange","year":"2023","unstructured":"Orange, S. T., Leslie, J., Ross, M., Mann, D. A., & Wackerhage, H. (2023). The exercise IL-6 enigma in cancer. Trends in Endocrinology and Metabolism, 34(11), 749\u2013763.","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"11011_CR130","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cytogfr.2023.10.003","volume":"75","author":"DP Anastasiadou","year":"2024","unstructured":"Anastasiadou, D. P., Quesnel, A., Duran, C. L., Filippou, P. S., & Karagiannis, G. S. (2024). An emerging paradigm of CXCL12 involvement in the metastatic cascade. Cytokine & Growth Factor Reviews, 75, 12\u201330.","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"11011_CR131","doi-asserted-by":"crossref","unstructured":"Fry, T. J., & Mackall, C. L. (2005). The many faces of IL-7: fom lymphopoiesis to peripheral T cell maintenance. J Immunol,\u00a0174(11), 6571\u20136.","DOI":"10.4049\/jimmunol.174.11.6571"},{"issue":"49","key":"11011_CR132","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","volume":"43","author":"R Antoon","year":"2024","unstructured":"Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024). Mesenchymal stromal cells as cancer promoters. Oncogene, 43(49), 3545\u20133555.","journal-title":"Oncogene"},{"issue":"1","key":"11011_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27666-w","volume":"18","author":"A Kim","year":"2018","unstructured":"Kim, A., Shim, S., Kim, M. J., Myung, J. K., & Park, S. (2018). Mesenchymal stem cell-mediated NotcH2 activation overcomes radiation-induced injury of the hematopoietic system. Scientific Reports, 18(1), Article 9277.","journal-title":"Scientific Reports"},{"issue":"11","key":"11011_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166027","volume":"11","author":"KC Vallabhaneni","year":"2016","unstructured":"Vallabhaneni, K. C., Hassler, M. Y., Abraham, A., Whitt, J., Mo, Y. Y., Atfi, A., et al. (2016). Mesenchymal stem\/stromal cells under stress increase osteosarcoma migration and apoptosis resistance via extracellular vesicle mediated communication. PLoS One, 11(11), Article e0166027.","journal-title":"PLoS One"},{"issue":"1","key":"11011_CR135","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1080\/21655979.2021.1955549","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. (2021). Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-\u03b3\/IL-6. Bioengineered, 12(1), 4500\u20134507.","journal-title":"Bioengineered"},{"issue":"16","key":"11011_CR136","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1334","volume":"6","author":"J Lim","year":"2020","unstructured":"Lim, J., Heo, J., Ju, H., Shin, J. W., Kim, Y., Lee, S., et al. (2020). Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway. Science Advances, 6(16), Article eaba1334.","journal-title":"Science Advances"},{"issue":"7","key":"11011_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.476","volume":"11","author":"J Lim","year":"2021","unstructured":"Lim, J., Heo, J., Yu, H. Y., Yun, H., Lee, S., Ju, H., et al. (2021). Small-sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft-versus-host disease. Clinical and Translational Medicine, 11(7), Article e476.","journal-title":"Clinical and Translational Medicine"},{"issue":"6","key":"11011_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217572","volume":"14","author":"L Hinden","year":"2019","unstructured":"Hinden, L., Avner, M., Stepensky, P., Or, R., & Almogi-Hazan, O. (2019). Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients. PLoS One, 14(6), Article e0217572.","journal-title":"PLoS One"},{"key":"11011_CR139","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211072838","volume":"13","author":"MZ Shen","year":"2022","unstructured":"Shen, M. Z., Liu, X. X., Qiu, Z. Y., Xu, L. P., Zhang, X. H., Wang, Y., et al. (2022). Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation. Therapeutic Advances in Hematology, 13, Article 20406207211072838.","journal-title":"Therapeutic Advances in Hematology"},{"issue":"3","key":"11011_CR140","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.transproceed.2019.01.023","volume":"51","author":"A Krasowska-Kwiecien","year":"2019","unstructured":"Krasowska-Kwiecien, A., Gozdzik, J., Jarocha, D., Wozniak, M., Czogala, W., Wiecha, O., et al. (2019). Mesenchymal stem cells as a salvage treatment for severe refractory graft-vs-host disease in children after bone marrow transplantation. Transplantation Proceedings, 51(3), 880\u2013889.","journal-title":"Transplantation Proceedings"},{"key":"11011_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.959658","volume":"13","author":"E Stenger","year":"2022","unstructured":"Stenger, E., Giver, C. R., Langston, A., Kota, D., Das, P. K., Chinnadurai, R., et al. (2022). Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Frontiers in Immunology, 13, Article 959658.","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"11011_CR142","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41409-021-01304-y","volume":"56","author":"M Murata","year":"2021","unstructured":"Murata, M., Terakura, S., Wake, A., Miyao, K., Ikegame, K., Uchida, N., et al. (2021). Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: Real-world evidence. Bone Marrow Transplantation, 56(10), 2355\u20132366.","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"11011_CR143","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00277-018-3250-8","volume":"97","author":"I Stoma","year":"2018","unstructured":"Stoma, I., Karpov, I., Krivenko, S., Iskrov, I., Milanovich, N., Koritko, A., et al. (2018). Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: Characteristics and risk factors for infectious complications. Annals Of Hematology, 97(5), 885\u2013891.","journal-title":"Annals Of Hematology"},{"issue":"7","key":"11011_CR144","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41409-018-0102-z","volume":"53","author":"P Bader","year":"2018","unstructured":"Bader, P., Ku\u00e7i, Z., Bakhtiar, S., Basu, O., Bug, G., Dennis, M., et al. (2018). Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM). Bone Marrow Transplantation, 53(7), 852\u2013862.","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"11011_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121577","volume":"8","author":"H Bonig","year":"2019","unstructured":"Bonig, H., Ku\u00e7i, Z., Ku\u00e7i, S., Bakhtiar, S., Basu, O., Bug, G., et al. (2019). Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation MSC-FFM-outcome report of 92 patients. Cells, 8(12), Article 1577.","journal-title":"Cells"},{"issue":"1","key":"11011_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04731-1","volume":"21","author":"H Bonig","year":"2023","unstructured":"Bonig, H., Verbeek, M., Herhaus, P., Braitsch, K., Beutel, G., Schmid, C., et al. (2023). Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease. Journal Of Translational Medicine, 21(1), Article 837.","journal-title":"Journal Of Translational Medicine"},{"issue":"1","key":"11011_CR147","first-page":"1","volume":"7","author":"H Kubota","year":"2024","unstructured":"Kubota, H., Arakawa, Y., Mizushima, Y., Irikura, T., Watakabe, M., Ishikawa, T., et al. (2024). Efficacy of off-the-shelf bone marrow mesenchymal stem cells for pediatric steroid-refractory acute graft-versus-host disease. Blood Cell Ther, 7(1), 1\u20139.","journal-title":"Blood Cell Ther"},{"issue":"11","key":"11011_CR148","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1038\/s41409-020-0910-9","volume":"55","author":"LE van der Wagen","year":"2020","unstructured":"van der Wagen, L. E., Miranda-Bedate, A., Janssen, A., Fernando, F., Appukudige, N., van Dooremalen, S., et al. (2020). Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile. Bone Marrow Transplantation, 55(11), 2188\u20132192.","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"11011_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03782-5","volume":"22","author":"E Jiang","year":"2024","unstructured":"Jiang, E., Qian, K., Wang, L., Yang, D., Shao, Y., Hu, L., et al. (2024). Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: A multicentre, randomized, double-blind, phase 2 trial. BMC Medicine, 22(1), Article 555.","journal-title":"BMC Medicine"},{"issue":"3","key":"11011_CR150","first-page":"186","volume":"36","author":"C Bozkurt","year":"2019","unstructured":"Bozkurt, C., Kara\u00f6z, E., Adakl\u0131 Aksoy, B., Aydo\u011fdu, S., & F\u0131\u015fg\u0131n, T. (2019). The use of allogeneic mesenchymal stem cells in childhood steroid-resistant acute graft-versus-host disease: A retrospective study of a single-center experience. Turk J Haematol: Off J Turk Soc Haematol, 36(3), 186\u2013192.","journal-title":"Turk J Haematol: Off J Turk Soc Haematol"},{"issue":"1","key":"11011_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80531-7","volume":"11","author":"Y Zu","year":"2021","unstructured":"Zu, Y., Zhou, J., Fu, Y., Fang, B., Liu, X., Zhang, Y., et al. (2021). Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA. Scientific Reports, 11(1), Article 253.","journal-title":"Scientific Reports"},{"issue":"1","key":"11011_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02562-x","volume":"21","author":"Y Lan","year":"2021","unstructured":"Lan, Y., Liu, F., Chang, L., Liu, L., Zhang, Y., Yi, M., et al. (2021). Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia. BMC Pediatrics, 21(1), Article 102.","journal-title":"BMC Pediatrics"},{"issue":"5","key":"11011_CR153","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/bmt.2016.347","volume":"52","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Zhang, Y., Xiao, H., Yao, Z., Zhang, H., Liu, Q., et al. (2017). Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: An interim summary for a multicenter phase II trial results. Bone Marrow Transplantation, 52(5), 704\u2013710.","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"11011_CR154","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/hon.2867","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Zheng, H., Ren, J., Luo, X., Zheng, Z., Zheng, J., et al. (2021). Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia. Hematological Oncology, 39(3), 380\u2013389.","journal-title":"Hematological Oncology"},{"issue":"5","key":"11011_CR155","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520920438","volume":"48","author":"X Wang","year":"2020","unstructured":"Wang, X., Zhang, M., & He, P. (2020). Pre-infusion single-dose mesenchymal stem cells promote platelet engraftment and decrease severe acute graft versus host disease without relapse in haploidentical peripheral blood stem cell transplantation. Journal of International Medical Research, 48(5), Article 300060520920438.","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"11011_CR156","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13905","volume":"25","author":"T Rostami","year":"2021","unstructured":"Rostami, T., Maleki, N., Kasaeian, A., Nikbakht, M., Kiumarsi, A., Asadollah Mousavi, S., et al. (2021). Co-transplantation of bone marrow-derived mesenchymal stem cells with hematopoietic stem cells does not improve transplantation outcome in class III beta-thalassemia major: A prospective cohort study with long-term follow-up. Pediatric Transplantation, 25(3), Article e13905.","journal-title":"Pediatric Transplantation"},{"issue":"1","key":"11011_CR157","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13287-021-02242-8","volume":"12","author":"T Rostami","year":"2021","unstructured":"Rostami, T., Kasaeian, A., Maleki, N., Nikbakht, M., Kiumarsi, A., Tavangar, S. M., et al. (2021). The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III \u03b2-thalassemia major. Stem Cell Research & Therapy, 12(1), 213.","journal-title":"Stem Cell Research & Therapy"},{"key":"11011_CR158","doi-asserted-by":"crossref","unstructured":"Lu, W., & Allickson, J. (2025 June). Mesenchymal stromal cell therapy: progress to date and future outlook. Mol Ther: J Am Soc Gene Ther, 4(6), 2679\u20132688.","DOI":"10.1016\/j.ymthe.2025.02.003"},{"issue":"1","key":"11011_CR159","first-page":"CD009768","volume":"1","author":"SA Fisher","year":"2019","unstructured":"Fisher, S. A., Cutler, A., Doree, C., Brunskill, S. J., Stanworth, S. J., Navarrete, C., et al. (2019). Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in Haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database Systematic Review, 1(1), CD009768.","journal-title":"Cochrane Database Systematic Review"},{"issue":"1","key":"11011_CR160","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13287-022-02751-0","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y., Hao, J., Hu, Z., Yang, Y. G., Zhou, Q., Sun, L., et al. (2022). Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: A systematic review. Stem Cell Research & Therapy, 13(1), 93.","journal-title":"Stem Cell Research & Therapy"},{"key":"11011_CR161","doi-asserted-by":"crossref","unstructured":"Qian, H., Le Blanc, K., & Sigvardsson, M. (2012). Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein. J Biol Chem, 287(31), 25795\u201325807.","DOI":"10.1074\/jbc.M112.339622"},{"key":"11011_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-019-0112-2","volume":"21","author":"L Zhou","year":"2019","unstructured":"Zhou, L., Liu, S., Wang, Z., Yao, J., Cao, W., Chen, S., et al. (2019). Bone marrow-derived mesenchymal stem cells modified with Akt1 ameliorates acute liver GVHD. Biological Procedures Online, 21, Article 24.","journal-title":"Biological Procedures Online"},{"issue":"12","key":"11011_CR163","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41375-018-0151-8","volume":"32","author":"Y Kim","year":"2018","unstructured":"Kim, Y., Jin, H. J., Heo, J., Ju, H., Lee, H. Y., Kim, S., et al. (2018). Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease. Leukemia, 32(12), 2672\u20132684.","journal-title":"Leukemia"},{"issue":"1","key":"11011_CR164","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13287-020-01659-x","volume":"11","author":"A\u00c9 Silva-Carvalho","year":"2020","unstructured":"Silva-Carvalho, A. \u00c9., Rodrigues, L. P., Schiavinato, J. L., Alborghetti, M. R., Bettarello, G., Sim\u00f5es, B. P., et al. (2020). GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, 11(1), 156.","journal-title":"Stem Cell Research & Therapy"},{"issue":"2","key":"11011_CR165","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12015-020-10058-x","volume":"17","author":"M Gupta","year":"2021","unstructured":"Gupta, M., Tieu, A., Slobodian, M., Shorr, R., Burger, D., Lalu, M. M., et al. (2021). Preclinical studies of MSC-derived extracellular vesicles to treat or prevent graft versus host disease: A systematic review of the literature. Stem Cell Reviews And Reports, 17(2), 332\u2013340.","journal-title":"Stem Cell Reviews And Reports"},{"key":"11011_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.617589","volume":"9","author":"KL Li","year":"2021","unstructured":"Li, K. L., Li, J. Y., Xie, G. L., & Ma, X. Y. (2021). Exosomes released from human bone marrow-derived mesenchymal stem cell attenuate acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in mice. Frontiers in Cell and Developmental Biology, 9, Article 617589.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"22","key":"11011_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221908","volume":"13","author":"AI Dorofeeva","year":"2024","unstructured":"Dorofeeva, A. I., Shipounova, I. N., Nikiforova, K. A., Galtseva, I. V., Kuzmina, L. A., Luchkin, A. V., et al. (2024). PDGF-BB deficiency in the blood serum from aplastic anemia patients affects bone marrow-derived multipotent mesenchymal stromal cells. Cells, 13(22), Article 1908.","journal-title":"Cells"},{"issue":"1","key":"11011_CR168","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13287-017-0620-4","volume":"8","author":"S Lu","year":"2017","unstructured":"Lu, S., Ge, M., Zheng, Y., Li, J., Feng, X., Feng, S., et al. (2017). CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-\u03baB in the bone marrow failure of acquired aplastic anemia. Stem Cell Research & Therapy, 8(1), 178.","journal-title":"Stem Cell Research & Therapy"},{"issue":"12","key":"11011_CR169","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.7150\/ijms.47273","volume":"17","author":"S Li","year":"2020","unstructured":"Li, S., Qin, M., Wu, R., Meng, H., He, Y., Wang, B., et al. (2020). Insensitive to PTH of CD8\u2009+\u2009T cells regulate bone marrow mesenchymal stromal cell in aplastic anemia patients. International Journal of Medical Sciences, 17(12), 1665\u20131672.","journal-title":"International Journal of Medical Sciences"},{"issue":"19","key":"11011_CR170","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1080\/15384101.2020.1807081","volume":"19","author":"H Li","year":"2020","unstructured":"Li, H., Xu, X., Wang, D., Zeng, L., Li, B., Zhang, Y., et al. (2020). MiR-146b-5p regulates bone marrow mesenchymal stem cell differentiation by SIAH2\/PPAR\u03b3 in aplastic anemia children and benzene-induced aplastic anemia mouse model. Cell Cycle, 19(19), 2460\u20132471.","journal-title":"Cell Cycle"},{"key":"11011_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107292","volume":"93","author":"H Li","year":"2021","unstructured":"Li, H., Xu, X., Wang, D., Zhang, Y., Chen, J., Li, B., et al. (2021). Hypermethylation-mediated downregulation of long non-coding RNA MEG3 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells and promotes pediatric aplastic anemia. International Immunopharmacology, 93, Article 107292.","journal-title":"International Immunopharmacology"},{"issue":"22","key":"11011_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212298","volume":"25","author":"YH Peng","year":"2024","unstructured":"Peng, Y. H., Li, C. W., Wu, K. H., Li, J. P., Yang, S. F., & Chao, Y. H. (2024). Up-regulated expression of thioredoxin-interacting protein (TXNIP) in mesenchymal stem cells associated with severe aplastic anemia in children. International Journal of Molecular Sciences, 25(22), Article 12298.","journal-title":"International Journal of Molecular Sciences"},{"key":"11011_CR173","doi-asserted-by":"crossref","unstructured":"Chao, Y. H., Lin, C. W., Pan, H. H., Yang, S. F., Weng, T. F., Peng, C. T., et al. (2018). Increased apoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymal stem cells in severe aplastic anemia. Pediatric Blood & Cancer\u00a065(9), e27247.","DOI":"10.1002\/pbc.27247"},{"issue":"2","key":"11011_CR174","doi-asserted-by":"publisher","first-page":"553","DOI":"10.18632\/aging.204500","volume":"15","author":"JP Li","year":"2023","unstructured":"Li, J. P., Wu, K. H., Chao, W. R., Lee, Y. J., Yang, S. F., & Chao, Y. H. (2023). Alterations of mesenchymal stem cells on regulating Th17 and Treg differentiation in severe aplastic anemia. Aging, 15(2), 553\u2013566.","journal-title":"Aging"},{"issue":"9","key":"11011_CR175","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/iub.2035","volume":"71","author":"Y Li","year":"2019","unstructured":"Li, Y., Wang, F., Guo, R., Zhang, Y., Chen, D., Li, X., et al. (2019). Exosomal sphingosine 1-phosphate secreted by mesenchymal stem cells regulated treg\/Th17 balance in aplastic anemia. IUBMB Life, 71(9), 1284\u20131292.","journal-title":"IUBMB Life"},{"issue":"1","key":"11011_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70369-8","volume":"14","author":"J Srivastava","year":"2024","unstructured":"Srivastava, J., Kundal, K., Rai, B., Saxena, P., Katiyar, S., Tripathy, N., et al. (2024). Global MicroRNA profiling of bone marrow-MSC derived extracellular vesicles identifies miRNAs associated with hematopoietic dysfunction in aplastic anemia. Scientific Reports, 14(1), Article 19654.","journal-title":"Scientific Reports"},{"issue":"1","key":"11011_CR177","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13287-023-03496-0","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang, S., Huo, J., Liu, Y., Chen, L., Ren, X., Li, X., et al. (2023). Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia. Stem Cell Research & Therapy, 14(1), 285.","journal-title":"Stem Cell Research & Therapy"},{"issue":"8","key":"11011_CR178","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12862","volume":"53","author":"Y Wei","year":"2020","unstructured":"Wei, Y., Zhang, L., Chi, Y., Ren, X., Gao, Y., Song, B., et al. (2020). High-efficient generation of VCAM-1\u2009+\u2009mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice. Cell Proliferation, 53(8), Article e12862.","journal-title":"Cell Proliferation"},{"issue":"2","key":"11011_CR179","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00277-018-3523-2","volume":"98","author":"ZK Wang","year":"2019","unstructured":"Wang, Z. K., Yu, H. J., Cao, F. L., Liu, Z. H., Liu, Z. Y., Feng, W. J., et al. (2019). Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children. Annals of Hematology, 98(2), 473\u2013479.","journal-title":"Annals of Hematology"},{"issue":"22","key":"11011_CR180","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1089\/scd.2017.0078","volume":"26","author":"LL Xu","year":"2017","unstructured":"Xu, L. L., Fu, H. X., Zhang, J. M., Feng, F. E., Wang, Q. M., Zhu, X. L., et al. (2017). Impaired function of bone marrow mesenchymal stem cells from immune thrombocytopenia patients in inducing regulatory dendritic cell differentiation through the Notch-1\/Jagged-1 signaling pathway. Stem Cells and Development, 26(22), 1648\u20131661.","journal-title":"Stem Cells and Development"},{"issue":"9","key":"11011_CR181","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1182\/bloodadvances.2018026690","volume":"3","author":"M Wang","year":"2019","unstructured":"Wang, M., Feng, R., Zhang, J. M., Xu, L. L., Feng, F. E., Wang, C. C., et al. (2019). Dysregulated megakaryocyte distribution associated with nestin\u2009+\u2009mesenchymal stem cells in immune thrombocytopenia. Blood Advances, 3(9), 1416\u20131428.","journal-title":"Blood Advances"},{"issue":"3","key":"11011_CR182","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjh.15034","volume":"180","author":"Y He","year":"2018","unstructured":"He, Y., Xu, L. L., Feng, F. E., Wang, Q. M., Zhu, X. L., Wang, C. C., et al. (2018). Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3\/NF-\u03baB\/SMAD pathway in patients with immune thrombocytopenia. British Journal of Haematology, 180(3), 395\u2013411.","journal-title":"British Journal of Haematology"},{"issue":"8","key":"11011_CR183","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3324\/haematol.2018.204446","volume":"104","author":"X Zhu","year":"2019","unstructured":"Zhu, X., Wang, Y., Jiang, Q., Jiang, H., Lu, J., Wang, Y., et al. (2019). All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement-interleukin-1\u03b2 loop. Haematologica, 104(8), 1661\u20131675.","journal-title":"Haematologica"},{"issue":"12","key":"11011_CR184","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.5966\/sctm.2015-0360","volume":"5","author":"JM Zhang","year":"2016","unstructured":"Zhang, J. M., Feng, F. E., Wang, Q. M., Zhu, X. L., Fu, H. X., Xu, L. P., et al. (2016). Platelet-derived growth factor-BB protects mesenchymal stem cells (MSCs) derived from immune thrombocytopenia patients against apoptosis and senescence and maintains MSC-mediated immunosuppression. Stem Cells Translational Medicine, 5(12), 1631\u20131643.","journal-title":"Stem Cells Translational Medicine"},{"issue":"5","key":"11011_CR185","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3892\/etm.2017.4229","volume":"13","author":"X Wang","year":"2017","unstructured":"Wang, X., Yin, X., Sun, W., Bai, J., Shen, Y., Ao, Q., et al. (2017). Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up. Experimental And Therapeutic Medicine, 13(5), 2255\u20132258.","journal-title":"Experimental And Therapeutic Medicine"},{"key":"11011_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1078421","volume":"13","author":"L Zheng","year":"2022","unstructured":"Zheng, L., Zhang, L., Guo, Y., Xu, X., Liu, Z., Yan, Z., et al. (2022). The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome. Frontiers in Immunology, 13, Article 1078421.","journal-title":"Frontiers in Immunology"},{"key":"11011_CR187","doi-asserted-by":"crossref","unstructured":"Qu, B., Han, X., Zhao, L., Zhang, F., & Gao, Q. (2022). Relationship of HIF\u20131\u03b1 expression with apoptosis and cell cycle in bone marrow mesenchymal stem cells from patients with myelodysplastic syndrome. Molecular Medicine Reports, 26(1), 239.","DOI":"10.3892\/mmr.2022.12755"},{"key":"11011_CR188","doi-asserted-by":"crossref","unstructured":"Eroz, I., Kakkar, P. K., Lazar, R. A., & El-Jawhari, J. (2014). Mesenchymal stem cells in myelodysplastic syndromes and leukaemia. Biomedicines ,\u00a012(8), 1677.","DOI":"10.3390\/biomedicines12081677"},{"issue":"10","key":"11011_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06197-x","volume":"14","author":"C Giallongo","year":"2023","unstructured":"Giallongo, C., Dulcamare, I., Giallongo, S., Duminuco, A., Pieragostino, D., Cufaro, M. C., et al. (2023). MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes. Cell Death and Disease, 14(10), Article 686.","journal-title":"Cell Death and Disease"},{"issue":"5","key":"11011_CR190","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130155","volume":"5","author":"D Sarhan","year":"2020","unstructured":"Sarhan, D., Wang, J., Sunil Arvindam, U., Hallstrom, C., Verneris, M. R., Grzywacz, B., et al. (2020). Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function. JCI Insight, 5(5), Article e130155.","journal-title":"JCI Insight"},{"issue":"8","key":"11011_CR191","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41375-020-0738-8","volume":"34","author":"M Meunier","year":"2020","unstructured":"Meunier, M., Guttin, A., Ancelet, S., Laurin, D., Zannoni, J., Lefebvre, C., et al. (2020). Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transfer. Leukemia, 34(8), 2249\u20132253.","journal-title":"Leukemia"},{"issue":"10","key":"11011_CR192","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41375-021-01275-5","volume":"35","author":"M Wobus","year":"2021","unstructured":"Wobus, M., Mies, A., Asokan, N., Oelschl\u00e4gel, U., M\u00f6bus, K., Winter, S., et al. (2021). Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells. Leukemia, 35(10), 2936\u20132947.","journal-title":"Leukemia"},{"issue":"1","key":"11011_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01231-z","volume":"21","author":"R Sabbah","year":"2023","unstructured":"Sabbah, R., Saadi, S., Shahar-Gabay, T., Gerassy, S., Yehudai-Resheff, S., & Zuckerman, T. (2023). Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development. Cell Communication and Signaling, 21(1), Article 277.","journal-title":"Cell Communication and Signaling"},{"issue":"2","key":"11011_CR194","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/2211-5463.13352","volume":"12","author":"J Phetfong","year":"2022","unstructured":"Phetfong, J., Tawonsawatruk, T., Kamprom, W., Ontong, P., Tanyong, D., Borwornpinyo, S., et al. (2022). Bone marrow-mesenchymal stem cell-derived extracellular vesicles affect proliferation and apoptosis of leukemia cells in vitro. Febs Open Bio, 12(2), 470\u2013479.","journal-title":"Febs Open Bio"},{"issue":"4","key":"11011_CR195","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3324\/haematol.2018.214379","volume":"105","author":"L Boutin","year":"2020","unstructured":"Boutin, L., Arnautou, P., Trignol, A., S\u00e9got, A., Farge, T., Desterke, C., et al. (2020). Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through side population functionality and ABC transporter activation. Haematologica, 105(4), 987\u20139998.","journal-title":"Haematologica"},{"issue":"6","key":"11011_CR196","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/s41388-019-1069-y","volume":"39","author":"F Kouzi","year":"2020","unstructured":"Kouzi, F., Zibara, K., Bourgeais, J., Picou, F., Gallay, N., Brossaud, J., et al. (2020). Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells. Oncogene, 39(6), 1198\u20131212.","journal-title":"Oncogene"},{"issue":"10","key":"11011_CR197","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/1541-7786.MCR-20-0091","volume":"18","author":"T Hack","year":"2020","unstructured":"Hack, T., Bertram, S., Blair, H., B\u00f6rger, V., B\u00fcsche, G., Denson, L., et al. (2020). Exposure of patient-derived mesenchymal stromal cells to TGFB1 supports fibrosis induction in a pediatric acute megakaryoblastic leukemia model. Molecular Cancer Research, 18(10), 1603\u20131612.","journal-title":"Molecular Cancer Research"},{"issue":"2","key":"11011_CR198","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41375-019-0568-8","volume":"34","author":"M Azadniv","year":"2020","unstructured":"Azadniv, M., Myers, J. R., McMurray, H. R., Guo, N., Rock, P., Coppage, M. L., et al. (2020). Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia, 34(2), 391\u2013403.","journal-title":"Leukemia"},{"key":"11011_CR199","doi-asserted-by":"publisher","first-page":"105734","DOI":"10.1016\/j.biocel.2020.105734","volume":"122","author":"M Mosleh","year":"2020","unstructured":"Mosleh, M., Safaroghli-Azar, A., & Bashash, D. (2020). Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance. International Journal of Biochemistry & Cell Biology, 122, 105734.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"6","key":"11011_CR200","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10245332.2017.1402455","volume":"23","author":"RC Schelker","year":"2018","unstructured":"Schelker, R. C., Iberl, S., M\u00fcller, G., Hart, C., Herr, W., & Grassinger, J. (2018). TGF-\u03b21 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells. Hematology, 23(6), 337\u2013345.","journal-title":"Hematology"},{"issue":"7","key":"11011_CR201","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bbamcr.2018.04.005","volume":"1865","author":"PP Ruvolo","year":"2018","unstructured":"Ruvolo, P. P., Ruvolo, V. R., Burks, J. K., Qiu, Y., Wang, R. Y., Shpall, E. J., et al. (2018). Role of MSC-derived galectin 3 in the AML microenvironment. Biochimica Et Biophysica Acta, 1865(7), 959\u2013969.","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"2","key":"11011_CR202","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3324\/haematol.2019.242974","volume":"106","author":"JJ Mistry","year":"2021","unstructured":"Mistry, J. J., Moore, J. A., Kumar, P., Marlein, C. R., Hellmich, C., Pillinger, G., et al. (2021). Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cells. Haematologica, 106(2), 589\u2013592.","journal-title":"Haematologica"},{"issue":"21","key":"11011_CR203","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1182\/bloodadvances.2023012077","volume":"8","author":"RJ Burt","year":"2024","unstructured":"Burt, R. J., Dey, A., Akarca, A., Allen, H., Amerikanou, R., Atkinson, S., et al. (2024). Mitochondrial DsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblasts. Blood Advances, 8(21), 5696\u20135709.","journal-title":"Blood Advances"},{"issue":"7","key":"11011_CR204","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1182\/bloodadvances.2022007528","volume":"7","author":"C Karantanou","year":"2023","unstructured":"Karantanou, C., Minciacchi, V. R., Kumar, R., Zanetti, C., Bravo, J., Pereira, R. S., et al. (2023). Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progression. Blood Advances, 7(7), 1190\u20131203.","journal-title":"Blood Advances"},{"issue":"23","key":"11011_CR205","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1182\/bloodadvances.2020004041","volume":"5","author":"M Chiu","year":"2021","unstructured":"Chiu, M., Taurino, G., Dander, E., Bardelli, D., Fallati, A., Andreoli, R., et al. (2021). All blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment. Blood Advances, 5(23), 5164\u20135178.","journal-title":"Blood Advances"},{"issue":"2","key":"11011_CR206","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001419","volume":"8","author":"SR Zanetti","year":"2020","unstructured":"Zanetti, S. R., Romecin, P. A., Vinyoles, M., Juan, M., Fuster, J. L., C\u00e1mos, M., et al. (2020). Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity. Journal for Immunotherapy of Cancer, 8(2), Article e001419.","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"11011_CR207","doi-asserted-by":"crossref","unstructured":"Vanegas, N. D. P., Ruiz-Aparicio, P. F., Uribe, G. I., Linares-Ballesteros, A., & Vernot, J. P. (2021). Leukemia-induced cellular senescence and stemness alterations in mesenchymal stem cells are reversible upon withdrawal of B-cell acute lymphoblastic leukemia cells. Int J Mol Sci, 22(15), 8166.","DOI":"10.3390\/ijms22158166"},{"issue":"6","key":"11011_CR208","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s12185-020-02981-z","volume":"112","author":"K Kihira","year":"2020","unstructured":"Kihira, K., Chelakkot, V. S., Kainuma, H., Okumura, Y., Tsuboya, N., Okamura, S., et al. (2020). Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells. International Journal of Hematology, 112(6), 795\u2013806.","journal-title":"International Journal of Hematology"},{"issue":"11","key":"11011_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05377-5","volume":"13","author":"C Tian","year":"2022","unstructured":"Tian, C., Li, Y., Wang, L., Si, J., Zheng, Y., Kang, J., et al. (2022). Blockade of FGF2\/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia. Cell Death and Disease, 13(11), Article 922.","journal-title":"Cell Death and Disease"},{"issue":"10","key":"11011_CR210","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1507\/endocrj.EJ21-0005","volume":"68","author":"T Yuan","year":"2021","unstructured":"Yuan, T., Shi, C., Xu, W., Yang, H. L., Xia, B., & Tian, C. (2021). Extracellular vesicles derived from T-cell acute lymphoblastic leukemia inhibit osteogenic differentiation of bone marrow mesenchymal stem cells via miR-34a-5p. Endocrine Journal, 68(10), 1197\u20131208.","journal-title":"Endocrine Journal"},{"issue":"1","key":"11011_CR211","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-018-0554-z","volume":"11","author":"J Wang","year":"2018","unstructured":"Wang, J., Liu, X., Qiu, Y., Shi, Y., Cai, J., Wang, B., et al. (2018). Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. Journal of Hematology & Oncology, 11(1), 11.","journal-title":"Journal of Hematology & Oncology"},{"issue":"11","key":"11011_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.370","volume":"7","author":"J Cai","year":"2016","unstructured":"Cai, J., Wang, J., Huang, Y., Wu, H., Xia, T., Xiao, J., et al. (2016). ERK\/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells. Cell Death and Disease, 7(11), Article e2459.","journal-title":"Cell Death and Disease"},{"issue":"19","key":"11011_CR213","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1182\/blood-2014-05-576421","volume":"125","author":"S Mallampati","year":"2015","unstructured":"Mallampati, S., Leng, X., Ma, H., Zeng, J., Li, J., Wang, H., et al. (2015). Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL\u2009+\u2009acute lymphoblastic leukemia. Blood, 125(19), 2968\u20132973.","journal-title":"Blood"},{"issue":"3","key":"11011_CR214","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2019.10.096","volume":"521","author":"YH Jiang","year":"2020","unstructured":"Jiang, Y. H., Liu, J., Lin, J., Li, S. Q., Xu, Y. M., Min, Q. H., et al. ((2020)). K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711. Biochemical and Biophysical Research Communications, 521(3), 584\u2013589.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"11011_CR215","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.7150\/thno.83178","volume":"13","author":"C Chai","year":"2023","unstructured":"Chai, C., Sui, K., Tang, J., Yu, H., Yang, C., Zhang, H., et al. (2023). BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. Theranostics, 13(12), 3943\u20133963.","journal-title":"Theranostics"},{"issue":"2","key":"11011_CR216","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03499-w","volume":"12","author":"S Zuo","year":"2021","unstructured":"Zuo, S., Sun, L., Wang, Y., Chen, B., Wang, J., Ge, X., et al. (2021). Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy. Cell Death and Disease, 12(2), Article 208.","journal-title":"Cell Death and Disease"},{"issue":"4","key":"11011_CR217","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s10517-019-04575-0","volume":"167","author":"NA Petinati","year":"2019","unstructured":"Petinati, N. A., Petrova, A. N., Chelysheva, E. Y., Shukhov, O. A., Bykova, A. V., Nemchenko, I. S., et al. (2019). Multipotent mesenchymal stromal cells in patients with chronic myeloid leukemia before discontinuation of tyrosine kinase inhibitors. Bulletin of Experimental Biology and Medicine, 167(4), 580\u2013583.","journal-title":"Bulletin of Experimental Biology and Medicine"},{"issue":"11","key":"11011_CR218","doi-asserted-by":"publisher","first-page":"21274","DOI":"10.1002\/jcp.28732","volume":"234","author":"Z Wan","year":"2019","unstructured":"Wan, Z., Chen, X., Gao, X., Dong, Y., Zhao, Y., Wei, M., et al. (2019). Chronic myeloid leukemia-derived exosomes attenuate adipogenesis of adipose derived mesenchymal stem cells via transporting miR-92a-3p. Journal of Cellular Physiology, 234(11), 21274\u201321283.","journal-title":"Journal of Cellular Physiology"},{"key":"11011_CR219","doi-asserted-by":"crossref","unstructured":"Dolinska, M., Cai, H., M\u00e5nsson, A., Shen, J., Xiao, P., Bouderlique, T. (2023) Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option. Blood, 142(1), 73\u201389.","DOI":"10.1182\/blood.2022016896"},{"issue":"7","key":"11011_CR220","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41375-018-0061-9","volume":"32","author":"S Xu","year":"2018","unstructured":"Xu, S., De Veirman, K., De Becker, A., Vanderkerken, K., & Van Riet, I. (2018). Mesenchymal stem cells in multiple myeloma: A therapeutical tool or target? Leukemia, 32(7), 1500\u20131514.","journal-title":"Leukemia"},{"issue":"9","key":"11011_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098157","volume":"24","author":"PM Rojas-Zambrano","year":"2023","unstructured":"Rojas-Zambrano, P. M., Meyer-Herrera, J. E., Ruiz-Aparicio, P. F., & Vernot, J. P. (2023). Simultaneously targeting two coupled signalling molecules in the mesenchymal stem cell support efficiently sensitises the multiple myeloma cell line H929 to bortezomib. International Journal of Molecular Sciences, 24(9), Article 8157.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"11011_CR222","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4252\/wjsc.v15.i5.421","volume":"15","author":"D Garc\u00eda-S\u00e1nchez","year":"2023","unstructured":"Garc\u00eda-S\u00e1nchez, D., Gonz\u00e1lez-Gonz\u00e1lez, A., Alfonso-Fern\u00e1ndez, A., Del Dujo-Guti\u00e9rrez, M., & P\u00e9rez-Campo, F. M. (2023). Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression. World Journal of Stem Cells, 15(5), 421\u2013437.","journal-title":"World Journal of Stem Cells"},{"issue":"6","key":"11011_CR223","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00432-024-05822-2","volume":"8","author":"M Vafaeizadeh","year":"2024","unstructured":"Vafaeizadeh, M., Abroun, S., & Soufi Zomorrod, M. (2024). Effect of human bone marrow mesenchymal stem cell-derived microvesicles on the apoptosis of the multiple myeloma cell line U266. Journal of Cancer Research and Clinical Oncology, 8(6), 299.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"11011_CR224","doi-asserted-by":"crossref","unstructured":"Da Ros, F., Kowal, K., Vicinanza, C., Lombardi, E., Agostini, F., Ciancia, R. (2023). IRE1a-induced FilaminA phosphorylation enhances migration of mesenchymal stem cells derived from multiple myeloma patients. Cells,\u00a012(15):1935.","DOI":"10.3390\/cells12151935"},{"issue":"5","key":"11011_CR225","doi-asserted-by":"publisher","DOI":"10.3390\/genes14051097","volume":"14","author":"NI Enukashvily","year":"2023","unstructured":"Enukashvily, N. I., Belik, L. A., Semenova, N. Y., Kostroma, I. I., Motyko, E. V., Gritsaev, S. V., et al. (2023). Transcription of WNT genes in hematopoietic niche\u2019s mesenchymal stem cells in multiple myeloma patients with different responses to treatment. Genes, 14(5), Article 1097.","journal-title":"Genes"},{"issue":"1","key":"11011_CR226","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-04399-9","volume":"18","author":"S Long","year":"2023","unstructured":"Long, S., Long, S., He, H., Luo, L., Liu, M., & Ding, T. (2023). Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6. Journal of Orthopaedic Surgery and Research, 18(1), Article 937.","journal-title":"Journal of Orthopaedic Surgery and Research"},{"issue":"3","key":"11011_CR227","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1224","volume":"13","author":"ZY Liu","year":"2023","unstructured":"Liu, Z. Y., Meng, N. H., Cao, P. P., Jia, Y., Wang, H., Zhang, Y. H., et al. (2023). Bone marrow-derived mesenchymal stem cells inhibit NK cell function via tim-3\/galectin-9 in multiple myeloma patients. Clinical and Translational Medicine, 13(3), Article e1224.","journal-title":"Clinical and Translational Medicine"},{"key":"11011_CR228","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.862524","volume":"10","author":"J Gu","year":"2022","unstructured":"Gu, J., Wang, M., Wang, X., Li, J., Liu, H., Lin, Z., et al. (2022). Exosomal miR-483-5p in bone marrow mesenchymal stem cells promotes malignant progression of multiple myeloma by targeting TIMP2. Frontiers in Cell and Developmental Biology, 10, Article 862524.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"7","key":"11011_CR229","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.861","volume":"12","author":"ZY Liu","year":"2022","unstructured":"Liu, Z. Y., Deng, L., Jia, Y., Liu, H., Ding, K., Wang, W., et al. (2022). CD155\/TIGIT signalling plays a vital role in the regulation of bone marrow mesenchymal stem cell-induced natural killer-cell exhaustion in multiple myeloma. Clinical and Translational Medicine, 12(7), Article e861.","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"11011_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20715-x","volume":"12","author":"A Garcia-Gomez","year":"2021","unstructured":"Garcia-Gomez, A., Li, T., de la Calle-Fabregat, C., Rodr\u00edguez-Ubreva, J., Ciudad, L., Catal\u00e0-Moll, F., et al. (2021). Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease. Nature Communications, 12(1), Article 421.","journal-title":"Nature Communications"},{"issue":"1","key":"11011_CR231","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cei.13594","volume":"205","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Mi, F., Han, M., Tian, M., Deng, L., Meng, N., et al. (2021). Bone marrow-derived mesenchymal stem cells inhibit CD8\u2009+\u2009T cell immune responses via PD-1\/PD-L1 pathway in multiple myeloma. Clinical and Experimental Immunology, 205(1), 53\u201362.","journal-title":"Clinical and Experimental Immunology"},{"key":"11011_CR232","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.trsl.2021.04.002","volume":"236","author":"M Dabbah","year":"2021","unstructured":"Dabbah, M., Lishner, M., Jarchowsky-Dolberg, O., Tartakover-Matalon, S., Brin, Y. S., Pasmanik-Chor, M., et al. (2021). Ribosomal proteins as distinct passengers of microvesicles: New semantics in myeloma and mesenchymal stem cells\u2019 communication. Translational Research, 236, 117\u2013132.","journal-title":"Translational Research"},{"key":"11011_CR233","doi-asserted-by":"crossref","unstructured":"Holthof, L. C., van der Schans, J. J., Katsarou, A., Poels, R., Gelderloos, A. T., Drent, E. (2021). Bone marrow mesenchymal stromal cells can render multiple myeloma cells resistant to cytotoxic machinery of CAR T cells through inhibition of apoptosis. Clin Cancer Res: Off J Am Assoc Cancer Res, 27(13), 3793\u2013803.","DOI":"10.1158\/1078-0432.CCR-20-2188"},{"issue":"7","key":"11011_CR234","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10529-021-03125-x","volume":"43","author":"J Zhao","year":"2021","unstructured":"Zhao, J., Ma, L., Ni, Z., & Liu, H. (2021). In vitro facilitating role of polygonatum sibiricum polysaccharide in osteogenic differentiation of bone marrow mesenchymal stem cells from patients with multiple myeloma. Biotechnology Letters, 43(7), 1311\u20131322.","journal-title":"Biotechnology Letters"},{"issue":"633","key":"11011_CR235","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aay8203","volume":"13","author":"Z Liu","year":"2020","unstructured":"Liu, Z., Liu, H., He, J., Lin, P., Tong, Q., & Yang, J. (2020). Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells. Science Signaling, 13(633), Article eaay8203.","journal-title":"Science Signaling"},{"issue":"2","key":"11011_CR236","first-page":"209","volume":"20","author":"G Zhang","year":"2020","unstructured":"Zhang, G., Miao, F., Xu, J., & Wang, R. (2020). Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13. Bosnian Journal of Basic Medical Sciences \/ Udru\u017eenje Basi\u010dnih Mediciniskih Znanosti = Association of Basic Medical Sciences, 20(2), 209\u2013217.","journal-title":"Bosnian Journal of Basic Medical Sciences \/ Udru\u017eenje Basi\u010dnih Mediciniskih Znanosti = Association of Basic Medical Sciences"},{"key":"11011_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2020.101406","volume":"67","author":"C Su","year":"2020","unstructured":"Su, C., Tao, D., Ren, L., Guo, S., Zhou, W., Wu, H., et al. (2020). The effective role of sodium copper chlorophyllin on the dysfunction of bone marrow mesenchymal stem cells in multiple myeloma via regulating TGF-\u03b21. Tissue And Cell, 67, Article 101406.","journal-title":"Tissue And Cell"},{"issue":"12","key":"11011_CR238","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/abbs\/gmz130","volume":"51","author":"J Jin","year":"2019","unstructured":"Jin, J., Cheng, S., Wang, Y., Wang, T., Zeng, D., Li, Z., et al. (2019). SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma. Acta Biochimica Et Biophysica Sinica, 51(12), 1258\u20131266.","journal-title":"Acta Biochimica Et Biophysica Sinica"},{"issue":"1","key":"11011_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38314-8","volume":"9","author":"RC Fernando","year":"2019","unstructured":"Fernando, R. C., Mazzotti, D. R., Azevedo, H., Sandes, A. F., Rizzatti, E. G., de Oliveira, M. B., et al. (2019). Transcriptome analysis of mesenchymal stem cells from multiple myeloma patients reveals downregulation of genes involved in cell cycle progression, immune response, and bone metabolism. Scientific Reports, 9(1), Article 1056.","journal-title":"Scientific Reports"},{"key":"11011_CR240","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.leukres.2017.07.002","volume":"60","author":"H Yang","year":"2017","unstructured":"Yang, H., Zheng, Y., Zhang, Y., Cao, Z., & Jiang, Y. (2017). Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-\u03baB signaling. Leukemia Research, 60, 82\u201388.","journal-title":"Leukemia Research"},{"issue":"3","key":"11011_CR241","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031823","volume":"24","author":"M Cippitelli","year":"2023","unstructured":"Cippitelli, M., Stabile, H., Kosta, A., Petillo, S., Lucantonio, L., Gismondi, A., et al. (2023). Role of NF-\u03baB signaling in the interplay between multiple myeloma and mesenchymal stromal cells. International Journal of Molecular Sciences, 24(3), Article 1823.","journal-title":"International Journal of Molecular Sciences"},{"key":"11011_CR242","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.leukres.2017.02.005","volume":"57","author":"P Zhao","year":"2017","unstructured":"Zhao, P., Chen, Y., Yue, Z., Yuan, Y., & Wang, X. (2017). Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway. Leukemia Research, 57, 20\u201326.","journal-title":"Leukemia Research"},{"key":"11011_CR243","doi-asserted-by":"crossref","unstructured":"Dabbah, M., Attar-Schneider, O., Tartakover Matalon, S., Shefler, I., Jarchwsky Dolberg, O., Lishner, M. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells\u2019 phenotype and translation initiation. Carcinogenesis, 38(7), 708\u201316.","DOI":"10.1093\/carcin\/bgx045"},{"issue":"1","key":"11011_CR244","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13287-023-03587-y","volume":"14","author":"J Li","year":"2023","unstructured":"Li, J., Wu, Z., Zhao, L., Liu, Y., Su, Y., Gong, X., et al. (2023). The heterogeneity of mesenchymal stem cells: An important issue to be addressed in cell therapy. Stem Cell Research & Therapy, 14(1), 381.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11011_CR245","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13287-021-02170-7","volume":"12","author":"R Li","year":"2021","unstructured":"Li, R., Tu, J., Zhao, J., Pan, H., Fang, L., & Shi, J. (2021). Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis. Stem Cell Research & Therapy, 12(1), 106.","journal-title":"Stem Cell Research & Therapy"},{"issue":"3","key":"11011_CR246","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/TA.0000000000003476","volume":"92","author":"X Wu","year":"2022","unstructured":"Wu, X., Darlington, D. N., Christy, B. A., Liu, B., Keesee, J. D., Salgado, C. L., et al. (2022). Intravenous administration of mesenchymal stromal cells leads to a dose-dependent coagulopathy and is unable to attenuate acute traumatic coagulopathy in rats. The Journal of Trauma and Acute Care Surgery, 92(3), 542\u2013552.","journal-title":"The Journal of Trauma and Acute Care Surgery"},{"issue":"6","key":"11011_CR247","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061320","volume":"10","author":"C Lechanteur","year":"2021","unstructured":"Lechanteur, C., Briquet, A., Bettonville, V., Baudoux, E., & Beguin, Y. (2021). MSC manufacturing for academic clinical trials: From a clinical-grade to a full GMP-compliant process. Cells, 10(6), Article 1320.","journal-title":"Cells"},{"key":"11011_CR248","doi-asserted-by":"crossref","unstructured":"Gong, X., Sun, D., Li, Z., Shi, Q., Li, D., & Ju, X. (2020). Three-dimensional culture of umbilical cord mesenchymal stem cells effectively promotes platelet recovery in immune thrombocytopenia. Biol Pharm Bull, 43(7), 1052\u201360.","DOI":"10.1248\/bpb.b19-01069"},{"issue":"6","key":"11011_CR249","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12722","volume":"25","author":"AG Quiroz-Reyes","year":"2022","unstructured":"Quiroz-Reyes, A. G., Gonz\u00e1lez-Villarreal, C. A., Mart\u00ednez-Rodriguez, H., Said-Fern\u00e1ndez, S., Salinas-Carmona, M. C., & Lim\u00f3n-Flores, A. Y. (2022). A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFN\u03b2 produces a synergistic activity in the reduction of lymphoma and mice survival enlargement. Molecular Medicine Reports, 25(6), Article 206.","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"11011_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020595","volume":"11","author":"AG Quiroz-Reyes","year":"2023","unstructured":"Quiroz-Reyes, A. G., Gonzalez-Villarreal, C. A., Limon-Flores, A. Y., Delgado-Gonzalez, P., Martinez-Rodriguez, H. G., Said-Fernandez, S. L., et al. (2023). Mesenchymal stem cells genetically modified by lentivirus-express soluble TRAIL and interleukin-12 inhibit growth and reduced metastasis-relate changes in lymphoma mice model. Biomedicines, 11(2), Article 595.","journal-title":"Biomedicines"},{"key":"11011_CR251","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhong, M., Zhong, W., Lan, Y., Yuan, Z., Duan, Y., et al. (2022). Construction of tandem Diabody (IL-6\/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma. Stem Cell Research & Therapy, 14(1), 473.","DOI":"10.1186\/s13287-022-03169-4"},{"issue":"2","key":"11011_CR252","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ymthe.2020.10.019","volume":"29","author":"X Wang","year":"2021","unstructured":"Wang, X., Cabrera, F. G., Sharp, K. L., Spencer, D. M., Foster, A. E., & Bayle, J. H. (2021). Engineering tolerance toward allogeneic CAR-T cells by regulation of MHC surface expression with human herpes Virus-8 proteins. Molecular Therapy, 29(2), 718\u2013733.","journal-title":"Molecular Therapy"},{"key":"11011_CR253","doi-asserted-by":"crossref","unstructured":"Fallati, A., Di Marzo, N., D\u2019Amico, G., & Dander, E. (2022). Mesenchymal stromal cells (MSCs): an ally of B-cell acute lymphoblastic leukemia (B-ALL) cells in disease maintenance and progression within the bone marrow hematopoietic niche. Cancers, 14(14), 3303.","DOI":"10.3390\/cancers14143303"},{"issue":"3","key":"11011_CR254","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030856","volume":"9","author":"AK Batsali","year":"2020","unstructured":"Batsali, A. K., Georgopoulou, A., Mavroudi, I., Matheakakis, A., Pontikoglou, C. G., & Papadaki, H. A. (2020). The role of bone marrow mesenchymal stem cell derived extracellular vesicles (MSC-EVs) in normal and abnormal hematopoiesis and their therapeutic potential. Journal of Clinical Medicine, 9(3), Article 856.","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"11011_CR255","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7633.1000365","volume":"6","author":"SV Boregowda","year":"2016","unstructured":"Boregowda, S. V., & Phinney, D. G. (2016). Quantifiable metrics for predicting MSC therapeutic efficacy. Journal of Stem Cell Research & Therapy, 6(11), Article 365.","journal-title":"Journal of Stem Cell Research & Therapy"},{"issue":"8","key":"11011_CR256","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/stmcls\/sxad039","volume":"41","author":"A Van Grouw","year":"2023","unstructured":"Van Grouw, A., Colonna, M. B., Maughon, T. S., Shen, X., Larey, A. M., Moore, S. G., et al. (2023). Development of a robust consensus modeling approach for identifying cellular and media metabolites predictive of mesenchymal stromal cell potency. Stem Cells, 41(8), 792\u2013808.","journal-title":"Stem Cells"},{"key":"11011_CR257","doi-asserted-by":"crossref","unstructured":"Jin, H. J., Bae, Y. K., Kim, M., Kwon, S. J., Jeon, H. B., Choi, S. J. (2013). Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci, 14(9), 17986\u201318001.","DOI":"10.3390\/ijms140917986"},{"issue":"3","key":"11011_CR258","doi-asserted-by":"publisher","DOI":"10.1093\/lifemedi\/lnaf016","volume":"4","author":"Z Hong","year":"2025","unstructured":"Hong, Z., Zhao, Y., Pahlavan, S., Wang, X., Han, S., Wang, X., et al. (2025). iPSC modification strategies to induce immune tolerance. Life Medicine, 4(3), Article lnaf016.","journal-title":"Life Medicine"},{"key":"11011_CR259","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.716907","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Chen, M., Liao, J., Chang, C., Liu, Y., Padhiar, A. A., et al. (2021). Induced pluripotent stem cell-derived mesenchymal stem cells hold lower heterogeneity and great promise in biological research and clinical applications. Frontiers in Cell and Developmental Biology, 9, Article 716907.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"11011_CR260","doi-asserted-by":"crossref","unstructured":"Movahed, A. Y., Bagheri, R., Savatier, P., \u0160ari\u0107, T., & Moradi, S. Elimination of tumorigenic pluripotent stem cells from their differentiated cell therapy products: An important step toward ensuring safe cell therapy. Stem Cell Reports, 20(7), 102543.","DOI":"10.1016\/j.stemcr.2025.102543"},{"issue":"8","key":"11011_CR261","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/stcltm\/szac039","volume":"11","author":"E Lezmi","year":"2022","unstructured":"Lezmi, E., & Benvenisty, N. (2022). The tumorigenic potential of human pluripotent stem cells. Stem Cells Translational Medicine, 11(8), 791\u2013796.","journal-title":"Stem Cells Translational Medicine"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-11011-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:02:38Z","timestamp":1768341758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-11011-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":261,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["11011"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-11011-6","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}